Moreover, we knocked down p16 in EPCs of smoking COPD patients, finding that the low expression of p16 could rescue the G1/S phase arrest of EPCs in those patients (Figure 2(e)). This evidence concerns the gene CDKN2A and chronic obstructive pulmonary disease.